ASP2408

DRUG4 trials

Sponsors

Astellas Pharma Global Development, Inc., Astellas Pharma Inc

Conditions

HealthyHealthy SubjectsPharmacokinetics of ASP2408Rheumatoid Arthritis

Phase 1

A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

CompletedNCT02052375

Astellas Pharma Global Development, Inc.Pharmacokinetics of ASP2408, Rheumatoid Arthritis

Start: 2012-06-30End: 2013-12-31Updated: 2014-02-06

A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects

CompletedNCT02125435

Astellas Pharma Global Development, Inc.Healthy Subjects, Pharmacokinetics of ASP2408

Start: 2011-01-31End: 2012-05-31Updated: 2014-04-29

A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

CompletedNCT02140125

Astellas Pharma IncHealthy, Pharmacokinetics of ASP2408

Start: 2012-08-31End: 2013-10-31Updated: 2014-07-01

A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections

CompletedNCT02150070

Astellas Pharma Global Development, Inc.Healthy Subjects, Pharmacokinetics of ASP2408

Start: 2011-08-31End: 2012-06-30Updated: 2014-05-29